---
title: "PRE: Secured $1B non-dilutive capital to accelerate growth, targeting $1B+ ARR by 2029"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292665619.md"
description: "Fastest-growing supplement brand achieved 42x revenue growth in 19 months, with FY 2026 revenue guidance raised to $210M–$220M and a $1B non-dilutive capital commitment secured. Cohort-based funding structure preserves shareholder value and supports a path to $1B+riginal document: Prenetics Global Limited [PRE] Slides Release — Jul. 14 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-14T18:53:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292665619.md)
  - [en](https://longbridge.com/en/news/292665619.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292665619.md)
generator: "portal-rs"
---

# PRE: Secured $1B non-dilutive capital to accelerate growth, targeting $1B+ ARR by 2029

Fastest-growing supplement brand achieved 42x revenue growth in 19 months, with FY 2026 revenue guidance raised to $210M–$220M and a $1B non-dilutive capital commitment secured. Cohort-based funding structure preserves shareholder value and supports a path to $1B+ ARR.

Original document: Prenetics Global Limited \[PRE\] Slides Release — Jul. 14 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [PRE.US](https://longbridge.com/en/quote/PRE.US.md)
- [PRENW.US](https://longbridge.com/en/quote/PRENW.US.md)

## Related News & Research

- [Prenetics restates FY2024, FY2023 results in audited annual report amendment](https://longbridge.com/en/news/298058286.md)
- [Prenetics Global director Caroline S. Levy files initial beneficial ownership statement](https://longbridge.com/en/news/297042951.md)
- [Sam Altman says AI needs to do more than cure cancer to win over skeptics](https://longbridge.com/en/news/298040546.md)
- [CRET: Q2 2026 saw higher sales and improved margins, but growth is limited by financing constraints](https://longbridge.com/en/news/297468890.md)
- [Iomart publishes 2026 annual report](https://longbridge.com/en/news/297739507.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**